Vir Biotechnology Inc (NASDAQ: VIR) on Friday, plunged -0.41% from the previous trading day, before settling in for the closing price of $7.37. Within the past 52 weeks, VIR’s price has moved between $6.56 and $13.09.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 421.39%. The company achieved an average annual earnings per share of 14.45%. With a float of $87.70 million, this company’s outstanding shares have now reached $136.71 million.
Considering the fact that the conglomerate employs 587 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vir Biotechnology Inc is 36.32%, while institutional ownership is 49.34%. The most recent insider transaction that took place on Dec 02 ’24, was worth 625. In this transaction EVP and General Counsel of this company sold 76 shares at a rate of $8.22, taking the stock ownership to the 56,973 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Officer proposed sale 76 for $8.22, making the entire transaction worth $625.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Vir Biotechnology Inc (VIR) is currently performing well based on its current performance indicators. A quick ratio of 8.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Compared to the last year’s volume of 1.08 million, its volume of 1.63 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.69%. Additionally, its Average True Range was 0.53.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 20.10%, which indicates a significant increase from 10.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.97% in the past 14 days, which was higher than the 65.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.02, while its 200-day Moving Average is $8.89. Nevertheless, the first resistance level for the watch stands at $7.52 in the near term. At $7.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.85. If the price goes on to break the first support level at $7.19, it is likely to go to the next support level at $7.05. Now, if the price goes above the second support level, the third support stands at $6.86.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
Market capitalization of the company is 1.01 billion based on 137,720K outstanding shares. Right now, sales total 86,180 K and income totals -615,060 K. The company made 2,380 K in profit during its latest quarter, and -213,720 K in sales during its previous quarter.
